Ticker > Company >

Jupiter Life Line share price

Jupiter Life Line Hospitals Ltd.

NSE: JLHL BSE: 543980 SECTOR: Hospital & Healthcare Services  41.42 K   28   14

1448.80
-28.50 (-1.93%)
NSE: 11 Sep 4:00 PM

Price Summary

Today's High

₹ 1488.9

Today's Low

₹ 1446

52 Week High

₹ 1770

52 Week Low

₹ 1263.2

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

9499.21 Cr.

Enterprise Value

9086.45 Cr.

No. of Shares

6.56 Cr.

P/E

50.7

P/B

6.48

Face Value

₹ 10

Div. Yield

0.07 %

Book Value (TTM)

₹  223.57

CASH

487.76 Cr.

DEBT

75 Cr.

Promoter Holding

40.91 %

EPS (TTM)

₹  28.57

Sales Growth

15.9%

ROE

13.85 %

ROCE

18.59%

Profit Growth

21.55 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year15.9%
3 Year17.27%
5 Year18.02%

Profit Growth

1 Year19.96%
3 Year29.49%
5 Year44.06%

ROE%

1 Year13.85%
3 Year19.56%
5 Year18.93%

ROCE %

1 Year18.59%
3 Year22.38%
5 Year19.86%

Debt/Equity

0.0527

Price to Cash Flow

43.2

Interest Cover Ratio

29.628

CFO/PAT (5 Yr. Avg.)

1.41101650220836

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 40.91 0.00
Mar 2025 40.91 0.00
Dec 2024 40.91 0.00
Sep 2024 40.91 0.00
Jun 2024 40.91 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 29.6917358385655% for the Past 3 years.
  • The company has shown a good revenue growth of 17.2693193607474% for the Past 3 years.
  • Company has been maintaining healthy ROCE of 22.3818666666667% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 29.628.
  • The Company has been maintaining an effective average operating margins of 22.995223997754% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of -106.3802 days.
  • Company has a healthy liquidity position with current ratio of 5.4772.
  • The company has a good cash flow management; CFO/PAT stands at 1.41101650220836.

 Limitations

  • The company is trading at a high PE of 50.7.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 240.87 273.1 269.13 273.91 277.94
Total Expenditure 183.73 203.66 201.69 201.71 210.41
Operating Profit 57.14 69.45 67.44 72.21 67.54
Other Income 6.78 9.26 8.13 6.95 12.88
Interest 0.95 1 2.65 4 3
Depreciation 7.98 10.41 10.64 13.38 16.67
Exceptional Items 0 0 0 0 0
Profit Before Tax 54.99 67.29 62.28 61.78 60.75
Tax 14.34 17 12.97 17.33 17.46
Profit After Tax 40.65 50.3 49.31 44.45 43.29
Adjusted EPS (Rs) 6.2 7.67 7.52 6.78 6.6

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 461.1 657.28 787.32 914.57 1060
Total Expenditure 393.58 498.43 583.29 687.26 790.78
Operating Profit 67.51 158.85 204.03 227.31 269.22
Other Income 5.59 3.75 13.3 25.69 28.14
Interest 28.17 29.23 27.71 18.66 8.61
Depreciation 27.38 27.66 28.61 30.52 42.41
Exceptional Items 0 0 -2.13 0 0
Profit Before Tax 17.55 105.71 158.88 203.82 246.34
Tax 0.96 21.04 51.67 51.87 61.64
Net Profit 16.59 84.67 107.21 153.26 183.84
Adjusted EPS (Rs.) 3.26 16.65 18.97 23.18 28.17

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 50.87 50.87 56.52 65.57 65.57
Total Reserves 202.47 278.01 408.51 1179.69 1356.98
Borrowings 258.15 297.88 294.69 0 74.25
Other N/C liabilities 22.56 24.7 25 27.04 91.98
Current liabilities 81.12 103.3 100.62 88.3 121.57
Total Liabilities 615.17 754.75 885.34 1360.6 1710.34
Assets
Net Block 426.42 464.58 476.47 477.32 713.2
Capital WIP 13.33 13.86 16.24 61.1 162.56
Intangible WIP 0 0 0 0 0
Investments 58.03 68.13 94.04 94.03 94.03
Loans & Advances 8.33 29.07 85.37 326.97 73.39
Other N/C Assets 0 2.78 16.37 17.45 1.28
Current Assets 109.06 176.32 196.84 383.72 665.88
Total Assets 615.17 754.75 885.34 1360.6 1710.34
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 17.55 105.71 158.88 203.82 246.34
Adjustment 54.41 53.95 48.65 24.97 23.98
Changes in Assets & Liabilities 50.98 -8.69 9.8 -69.32 11.94
Tax Paid -9.79 -8.62 -33.3 -49.68 -62.39
Operating Cash Flow 113.15 142.35 184.03 109.79 219.88
Investing Cash Flow -78.22 -68.92 -129.66 -238.04 -173.29
Financing Cash Flow -23.43 10.28 -23.23 121.88 301.84
Net Cash Flow 11.5 83.7 31.15 -6.36 348.43

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 40.91 40.91 40.91 40.91 40.91
ajay p thakker 20.74 20.74 20.74 20.74 20.74
ajay p thakker huf 0.01 0.01 0.01 0.01 0.01
ankit thakker 6.67 6.67 6.67 6.67 6.67
devang vasantlal gandhi 0.63 0.63 0.63 0.63 0.63
kirtika ajay thakker 2.03 2.03 2.03 2.03 2.03
neeta devang gandhi 2.10 2.10 2.10 2.10 2.10
nikita ankit thakker 0.02 0.02 0.02 0.02 0.02
western medical solutions... 8.70 8.70 8.70 8.70 8.70
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 59.09 59.09 59.09 59.09 59.09
a s arvind 1.48 1.21 1.21 1.21 1.21
brijesh ramakant tibrewal... 1.82 1.82 1.82 1.82 1.82
darshana mitesh chothani 1.93 - 1.03 1.11 1.09
dr navin ramji davda 2.01 2.00 2.00 2.00 2.00
girish shamji gala - - - - 1.02
goldman sachs funds - gol... 1.51 2.25 2.34 2.34 2.34
j m financial and investm... 1.91 1.91 1.91 1.91 1.91
jm financial products lim... 3.42 3.42 3.42 3.42 3.42
kamini arvind rao 3.00 3.27 - 3.27 3.27
mahesh ramakant tibrewala... 1.82 1.82 1.82 1.82 1.82
mihir wire industries pvt... 2.15 2.15 2.15 2.15 2.15
nitin manilal thakker 3.39 2.17 2.17 1.86 1.86
rajesh hiralal vora 1.22 1.22 1.22 1.22 1.22
ramakant jagdish tibrewal... 1.87 1.87 1.87 1.87 1.87
sbi healthcare opportunit... 8.07 8.19 7.32 7.29 0.73
sbi life insurance co. lt... - - - - 1.14
snk investments private l... - 1.39 1.39 1.39 1.39
sushma ramakant tibrewala... 1.23 1.23 1.22 1.22 1.22
custody bank of japan, lt... 1.38 1.53 1.40 - -
kamini a rao - - 3.27 - -
axis mutual fund trustee ... 1.19 1.03 - - -
persepolis investment com... 1.39 - - - -

Annual Reports

Title Link
Title Link
 No Annual reports exist for this company.Report us

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit ICRA
Credit CARE
TYPE AGENCY Link
TYPE AGENCY Link
Research Ventura

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q4FY25
Concall Q4FY24
Concall Q3FY24
Concall Q2FY24
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY24
Presentation Q3FY25
Presentation Q3FY24
Presentation Q2FY24
Presentation Q1FY25
Presentation Q1FY24

Company News

Jupiter Life Line Stock Price Analysis and Quick Research Report. Is Jupiter Life Line an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Jupiter Life Line. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Jupiter Life Line has a PE ratio of 50.7041464848672 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Jupiter Life Line has ROA of 12.029% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Jupiter Life Line has a Current ratio of 5.4772.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Jupiter Life Line has a ROE of 13.8468%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Jupiter Life Line has a Debt to Equity ratio of 0.0527 which means that the company has low proportion of debt in its capital.

  • Sales growth: Jupiter Life Line has reported revenue growth of 15.9014% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Jupiter Life Line for the current financial year is 25.3980667888053%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Jupiter Life Line is Rs 1 and the yield is 0.069%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Jupiter Life Line is Rs 28.5736. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Jupiter Life Line in Ticker for free. Also, one can get the intrinsic value of Jupiter Life Line by using Valuation Calculators, which are available with a Finology ONE subscription. 

Jupiter Life Line FAQs

Q1. What is Jupiter Life Line share price today?
Ans: The current share price of Jupiter Life Line is Rs 1448.8.

Q2. What is the market capitalisation of Jupiter Life Line?
Ans: Jupiter Life Line has a market capitalisation of Rs 9499.20526736 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Jupiter Life Line?
Ans: The PE ratio of Jupiter Life Line is 50.7041464848672 and the P/B ratio of Jupiter Life Line is 6.48040134832426, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Jupiter Life Line share?
Ans: The 52-week high share price of Jupiter Life Line is Rs 1770, and the 52-week low share price of Jupiter Life Line is Rs 1263.2.

Q5. Does Jupiter Life Line pay dividends?
Ans: Currently, Jupiter Life Line pays dividends. Dividend yield of Jupiter Life Line is around 0.069%.

Q6. What are the face value and book value of Jupiter Life Line shares?
Ans: The face value of Jupiter Life Line shares is Rs 10, while the book value per share of Jupiter Life Line is around Rs 223.5664. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Jupiter Life Line?
Ans: Jupiter Life Line has a total debt of Rs 75 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Jupiter Life Line?
Ans: The ROE of Jupiter Life Line is 13.8468% and ROCE of Jupiter Life Line is 18.5904%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Jupiter Life Line a good buy for the long term?
Ans: The Jupiter Life Line long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Jupiter Life Line undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Jupiter Life Line appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Jupiter Life Line’s financials?
Ans: You can review Jupiter Life Line’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Jupiter Life Line
X